US Patent 11666594 Antibody-drug conjugates comprising a cyclic dinucleotide
Patent 11666594 was granted and assigned to Takeda Pharmaceutical Company on June, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 7, 2020
0
Date of Patent
June 6, 2023
0
Patent Applicant
Patent Application Number
17065242
0
Patent Citations
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11666594 Antibody-drug conjugates comprising a cyclic dinucleotide
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
